Cytomegalovirus (CMV)
Showing 1 - 25 of 874
Maternal Cytomegalovirus Infections, Cytomegalovirus Congenital Trial in Birmingham (CMV Risk-Reduction Intervention, Stress
Recruiting
- Maternal Cytomegalovirus Infections
- Cytomegalovirus Congenital
- CMV Risk-Reduction Intervention
- Stress Reduction Messaging
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Dec 13, 2022
Cmv Congenital, CMV Viremia Trial in São Paulo (Women Enrolled, Newborns of Female Study Participants)
Not yet recruiting
- Cmv Congenital
- CMV Viremia
- Women Enrolled
- Newborns of Female Study Participants
-
São Paulo, BrazilUniversity of Sao Paulo
Aug 17, 2022
Pediatric and Adult Liver Transplant Recipients in China
Not yet recruiting
- Cytomegalovirus (CMV) Infections Among Children and Adult Liver Transplantation Patients in China
- (no location specified)
Jul 21, 2023
Infections, Cytomegalovirus Trial in Cordoba (Letermovir 240 mg Oral Tablet)
Not yet recruiting
- Infections, Cytomegalovirus
- Letermovir 240 mg Oral Tablet
-
Cordoba, Córdoba, SpainHospital Universitario Reina Sofia
Sep 25, 2023
Cytomegalovirus Infection Outcomes Among Solid Organ Transplant
Not yet recruiting
- Cytomegalovirus (CMV)
- (no location specified)
Oct 18, 2022
Cytomegalovirus Infection Outcomes Among Hematopoietic Stem Cell
Not yet recruiting
- Cytomegalovirus (CMV)
- (no location specified)
Oct 11, 2022
Liver Transplant Trial in United States (CMV-MVA Triplex, Placebo for CMV-MVA Triplex)
Not yet recruiting
- Liver Transplant
- CMV-MVA Triplex
- Placebo for CMV-MVA Triplex
-
Redwood City, California
- +16 more
Oct 10, 2023
Cytomegaloviral Infection, Hematopoietic and Lymphoid System Tumor Trial in Buffalo (Allogeneic Hematopoietic Stem Cell
Not yet recruiting
- Cytomegaloviral Infection
- Hematopoietic and Lymphoid System Neoplasm
- Allogeneic Hematopoietic Stem Cell Transplantation
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Dec 16, 2022
Cytomegalovirus Infection Trial in Boston (mRNA-1647, Placebo)
Not yet recruiting
- Cytomegalovirus Infection
- mRNA-1647
- Placebo
-
Boston, MassachusettsDana-Farber Cancer Institute
Jan 4, 2023
Cytomegalovirus Infections, Primary Immune Deficiency Disorder Trial in United States (viral specific cytotoxic t-lymphocytes)
Recruiting
- Cytomegalovirus Infections
- Primary Immune Deficiency Disorder
- viral specific cytotoxic t-lymphocytes
-
Los Angeles, California
- +7 more
Sep 27, 2022
Cytomegalovirus Infections, Haematological Malignancy, Organ or Tissue Transplant; Complications Trial in Parkville (Blood
Enrolling by invitation
- Cytomegalovirus Infections
- +3 more
- Blood sampling
-
Parkville, Victoria, AustraliaRoyal Melbourne Hospital
Apr 28, 2022
Congenital Cytomegaloviral (CMV) Disease Trial in United States (CMV Cytotoxic T-Lymphocytes, Anti-viral Therapy)
Recruiting
- Congenital Cytomegaloviral (CMV) Disease
- CMV Cytotoxic T-Lymphocytes
- Anti-viral Therapy
-
Saint Louis, Missouri
- +3 more
Oct 24, 2022
CMV* Reactivation and Anti-cytokine Treatment in Critical
Completed
- COVID-19, Cytomegalovirus (CMV), Tocilizumab, Anakinra, Mortality
- CMV DNA analysis
-
Istanbul, TurkeyHisar Hospital Intercontinental
Jun 13, 2022
Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Cytomegalovirus, Donor Trial in Columbus (Allogeneic
Recruiting
- Allogeneic Hematopoietic Stem Cell Transplantation Recipient
- +3 more
- Allogeneic Cytomegalovirus-Specific Cytotoxic T lymphocytes
-
Columbus, Ohio
- +1 more
Apr 20, 2022
Cytomegalovirus Infection Trial in North Hollywood, San Diego, Honolulu (mRNA-1647, Placebo)
Active, not recruiting
- Cytomegalovirus Infection
- mRNA-1647
- Placebo
-
North Hollywood, California
- +2 more
Dec 3, 2022
Glioblastoma Trial (PEP-CMV vaccine)
Not yet recruiting
- Glioblastoma
- PEP-CMV vaccine
- (no location specified)
Nov 9, 2023
Hearing Loss, Cochlear, Cytomegalovirus Congenital Trial in Paris (collection of sample of perilymphatic fluid during cochlear
Recruiting
- Hearing Loss, Cochlear
- Cytomegalovirus Congenital
- collection of sample of perilymphatic fluid during cochlear implantation
-
Paris, FranceRobert Debré Hospital
Apr 15, 2022
The Incidence of Peripheral Blood CMV Activation and Confirmed Clinically Significant CMV Infection Within 24 Weeks After
Not yet recruiting
- The Incidence of Peripheral Blood CMV Activation and Confirmed Clinically Significant CMV Infection Within 24 Weeks After Transplantation
- (no location specified)
Jun 13, 2023
Cytomegalovirus Infection Trial in United States (mRNA-1647, Placebo)
Completed
- Cytomegalovirus Infection
- mRNA-1647
- Placebo
-
Sacramento, California
- +8 more
Jan 11, 2023
CMV Infection, Cytomegalovirus Infections, CMV Viremia Trial in Madison (CMV-specific T-cells)
Recruiting
- CMV Infection
- +3 more
- CMV-specific T-cells
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Dec 10, 2021
Factors of CMV Reactivation in Patients Receiving of CAR-T Cells
Not yet recruiting
- Cytomegalovirus Infections
- +2 more
- (no location specified)
Sep 22, 2023